Novel Oral HIF-2 Alpha Inhibitor PT2977 - 100098

Spotlight
Video

Novel Oral HIF-2 Alpha Inhibitor PT2977

kidneycancer has 684 videos Subscribe Here

Loading........
Description: Toni Choueiri M.D. Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Women’s Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School Discusses Novel Oral HIF-2 Alpha Inhibitor PT2977. At The Fourteenth European International Kidney Cancer Symposium on Mar 29, 2019.
Shared By : kidneycancer
Posted on : 04/17/19
Added : 1 month ago
Category : Kidney Cancer